Skip to main content
Premium Trial:

Request an Annual Quote

Paired Ends: Feb 8, 2011


BioNanomatrix's board has appointed Erik Holmlin as CEO, president, and director, succeeding Edward Erickson, who is now CEO at Saladax Biomedical.

Prior to joining BioNanomatrix, Holmlin served as CEO and president of GenVault, which merged with IntegenX last month. Prior to that he was chief commercial officer at Exiqon, where he was responsible for global sales, marketing, and clinical affairs for oncology services in a CLIA lab and a consumables business. In 2001, he founded molecular diagnostics company GeneOhm Sciences, which was acquired by Becton Dickinson in 2006.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.